Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target

Abstract

Background

We explored the influence of low-dose intravenous alteplase and intensive blood pressure lowering on outcomes of acute ischemic stroke according to status/location of vascular obstruction in participants of the Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED).

Methods

ENCHANTED was a multicenter, quasi-factorial, randomized trial to determine efficacy and safety of low- versus standard-dose intravenous alteplase and intensive- versus guideline-recommended blood pressure lowering in acute ischemic stroke patients. In those who had baseline computed tomography or magnetic resonance imaging angiography, the degree of vascular occlusion was grouped according to being no (NVO), medium (MVO), or large (LVO). Logistic regression models were used to determine 90-day outcomes (modified Rankin scale [mRS] shift [primary], other mRS cut-scores, intracranial hemorrhage, early neurologic deterioration, and recanalization) by vascular obstruction status/site. Heterogeneity in associations for outcomes across subgroups was estimated by adding an interaction term to the models.

Results

There were 940 participants: 607 in alteplase arm only, 243 in blood pressure arm only, and 90 assigned to both arms. Compared to the NVO group, functional outcome was worse in LVO (mRS shift, adjusted OR [95% CI] 2.13 [1.56–2.90]) but comparable in MVO (1.34 [0.96–1.88]) groups. There were no differences in associations of alteplase dose or blood pressure lowering and outcomes across NVO/MVO/LVO groups (mRS shift: low versus standard alteplase dose 0.84 [0.54–1.30]/0.48 [0.25–0.91]/0.99 [0.75–2.09], P_interaction = 0.28; intensive versus standard blood pressure lowering 1.32 [0.74–2.38]/0.78 [0.31–1.94]/1.24 [0.64–2.41], P_interaction = 0.41), except for a borderline significant difference for intensive blood pressure lowering and increased early neurologic deterioration (0.63 [0.14–2.72]/0.17 [0.02–1.47]/2.69 [0.90–8.04], P_interaction = 0.05).

Conclusions

Functional outcome by dose of alteplase or intensity of blood pressure lowering is not modified by vascular obstruction status/site according to analyses from ENCHANTED, although these results are compromised by low statistical power.

Clinical Trial Registration: http://www.clinicaltrials.gov. Unique identifiers: NCT01422616

Keywords

Acute ischemic stroke arterial obstruction thrombolysis alteplase blood pressure reduction ENCHANTED trial

Get full access to this article

View all access options for this article.

References

Puig

Shankar

Liebeskind

, et al. From “time is brain” to “imaging is brain”: A paradigm shift in the management of acute ischemic stroke. J Neuroimaging 2020; 30: 562–571.

De Silva

Brekenfeld

Ebinger

, et al. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2010; 41: 295–299.

Mair

von Kummer

Adami

, et al. Arterial obstruction on computed tomographic or magnetic resonance angiography and response to intravenous thrombolytics in ischemic stroke. Stroke 2017; 48: 353–360.

Kimura

Iguchi

Shibazaki

Sakamoto

Watanabe

. Intravenous tissue plasminogen activator thrombolysis in patients without major arterial occlusion seems to be safe and effective. Eur Neurol 2010; 64: 258–264.

Ospel

Menon

Demchuk

, et al. Clinical course of acute ischemic stroke due to medium vessel occlusion with and without intravenous alteplase treatment. Stroke 2020; 51: 3232–3240.

Anderson

Robinson

Lindley

, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 2016; 374: 2313–2323.

Anderson

Huang

Lindley

, et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Lancet 2019; 393: 877–888.

Delcourt

Wang

Zhou

, et al. Brain imaging abnormalities and outcome after acute ischaemic stroke: the ENCHANTED trial. J Neurol Neurosurg Psychiatry 2020; 91: 1290–1296.

Tan

Demchuk

Hopyan

, et al. CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. Am J Neuroradiol 2009; 30: 525–531.

10.

Menon

Al-Ajlan

Najm

, et al. Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke. JAMA 2018; 320: 1017–1026.

11.

Menon

d'Esterre

Qazi

, et al. Multiphase CT angiography: a new tool for the imaging triage of patients with acute ischemic stroke. Radiology 2015; 275: 510–520.

12.

Hacke

Kaste

Fieschi

, et al. Randomised double-blind placebo controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 1998; 352: 1245–1251.

13.

Rai

Cline

Williams

Carpenter

Roberts

. Intravenous thrombolysis outcomes in patients presenting with large vessel acute ischemic strokes – CT angiography-based prognosis. J Neuroimaging 2015; 25: 238–242.

14.

Giralt-Steinhauer

Ois

Abilleira

, et al. Frequency and outcome of total anterior circulation strokes without intracranial large-vessel occlusion. Eur J Neurol 2017; 24: 11–17.

15.

Robinson

Wang

Arima

, et al. Low-versus standard-dose alteplase in patients on prior antiplatelet therapy: the ENCHANTED trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study). Stroke 2017; 48: 1877–1883.

16.

Petersen

Ortega-Gutierrez

Wang

, et al. Decreases in blood pressure during thrombectomy are associated with larger infarct volumes and worse functional outcome. Stroke 2019; 50: 1797–1804.

17.

Minhas

Wang

Lindley

, et al. Comparative effects of intensive-versus standard-BP lowering treatment in patients with severe ischemic stroke in the ENCHANTED trial. J Hypertens 2021; 39: 280–285.

18.

Zhou

Xia

Carcel

, et al. Intensive versus guideline-recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: the ENCHANTED trial. Eur J Neurol 2021; 28: 783–793.

19.

Malhotra

Goyal

Tsivgoulis

. Internal carotid artery occlusion: pathophysiology, diagnosis, and management. Curr Atheroscler Rep 2017; 19: 41.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.80 MB